PANI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.813
AS - Asia 9.948
EU - Europa 7.100
SA - Sud America 1.575
Continente sconosciuto - Info sul continente non disponibili 343
AF - Africa 254
OC - Oceania 108
Totale 44.141
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.058
SG - Singapore 2.540
CN - Cina 2.434
IT - Italia 1.978
HK - Hong Kong 1.684
GB - Regno Unito 1.567
BR - Brasile 1.212
VN - Vietnam 939
BD - Bangladesh 668
SE - Svezia 489
RU - Federazione Russa 430
FI - Finlandia 429
DE - Germania 409
KR - Corea 383
FR - Francia 380
CA - Canada 377
NL - Olanda 246
IN - India 236
BG - Bulgaria 199
IE - Irlanda 184
ID - Indonesia 171
LT - Lituania 124
TR - Turchia 122
AR - Argentina 116
MX - Messico 107
JP - Giappone 106
ES - Italia 103
PL - Polonia 91
IQ - Iraq 83
AU - Australia 82
MY - Malesia 73
AE - Emirati Arabi Uniti 72
UA - Ucraina 70
CO - Colombia 65
ZA - Sudafrica 65
EC - Ecuador 60
AT - Austria 59
PK - Pakistan 52
PH - Filippine 51
NO - Norvegia 49
CH - Svizzera 48
IL - Israele 47
TW - Taiwan 45
CR - Costa Rica 43
EG - Egitto 38
JM - Giamaica 36
VE - Venezuela 34
BE - Belgio 31
CL - Cile 30
CZ - Repubblica Ceca 29
TH - Thailandia 29
HN - Honduras 28
GT - Guatemala 27
MA - Marocco 27
UZ - Uzbekistan 26
NZ - Nuova Zelanda 25
SA - Arabia Saudita 24
SC - Seychelles 24
GR - Grecia 23
PY - Paraguay 23
TT - Trinidad e Tobago 22
NP - Nepal 20
PT - Portogallo 20
SV - El Salvador 20
JO - Giordania 19
PR - Porto Rico 19
DZ - Algeria 18
HU - Ungheria 17
KH - Cambogia 17
PE - Perù 17
NI - Nicaragua 16
RS - Serbia 16
IR - Iran 15
TN - Tunisia 15
DK - Danimarca 14
RO - Romania 14
DO - Repubblica Dominicana 13
AZ - Azerbaigian 11
EU - Europa 11
KE - Kenya 11
NG - Nigeria 11
UY - Uruguay 11
AL - Albania 10
BB - Barbados 10
EE - Estonia 10
KZ - Kazakistan 10
PA - Panama 10
PS - Palestinian Territory 10
AM - Armenia 9
HR - Croazia 9
SK - Slovacchia (Repubblica Slovacca) 9
ET - Etiopia 8
SI - Slovenia 7
BS - Bahamas 6
CW - ???statistics.table.value.countryCode.CW??? 6
MD - Moldavia 6
SY - Repubblica araba siriana 6
BA - Bosnia-Erzegovina 5
CY - Cipro 5
KG - Kirghizistan 5
Totale 43.688
Salva come PNG Salva come JPEG
Città #
Ashburn 3.035
Santa Clara 2.113
Fairfield 1.778
Hong Kong 1.636
Singapore 1.450
Chandler 1.102
San Jose 1.001
Woodbridge 799
Council Bluffs 739
Houston 715
Seattle 712
Hefei 640
London 620
Wilmington 602
Cambridge 553
Los Angeles 516
New York 473
The Dalles 459
Southend 450
Helsinki 389
Beijing 366
Nyköping 356
Seoul 350
Chicago 311
Ho Chi Minh City 283
Hanoi 269
Milan 254
Ann Arbor 241
Princeton 236
San Diego 222
Dallas 219
Lauterbourg 209
Modena 202
Sofia 195
Dublin 180
Buffalo 179
Rome 149
São Paulo 133
Jakarta 129
Boardman 128
Atlanta 123
Shanghai 120
Salt Lake City 116
North Bergen 108
Moscow 101
Denver 93
Phoenix 93
Vilnius 90
San Francisco 85
Frankfurt am Main 83
Orem 79
Warsaw 75
Toronto 74
Brooklyn 71
Tokyo 71
Amsterdam 68
Montreal 68
Redondo Beach 64
Boston 63
Utrecht 61
Bologna 60
Mexico City 56
Da Nang 53
Miami 53
Washington 53
Melbourne 52
Elk Grove Village 50
Naples 50
Dearborn 49
Nuremberg 48
Saint Augustine 47
Reggio Emilia 46
Haiphong 45
Stockholm 45
Chennai 44
Columbus 44
Norfolk 44
Munich 43
Tampa 43
Philadelphia 42
Izmir 41
Guangzhou 40
Eugene 39
Vancouver 39
Kent 37
Norwalk 37
Oslo 37
Rio de Janeiro 37
Edinburgh 36
Miano 36
Paris 36
Parma 36
Vienna 36
Charlotte 35
Brasília 34
Las Vegas 34
San José 34
Johannesburg 32
Turin 32
Pittsburgh 31
Totale 27.785
Salva come PNG Salva come JPEG
Nome #
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup 1.374
Safety and Efficacy of Red Yeast Rice Phytocomplex and Lovastatin: a Comparative Analysis 1.057
(-)S amisulpride binds with high affinity to cloned dopamine D3 and D2 receptors 401
VORTIOXETINE ATTENUATES NEUROINFLAMMATION BY MODULATING THE NOD-LIKE RECEPTOR FAMILY PYRIN DOMAIN CONTAINING 3 INFLAMMASOME ACTIVATION IN MICROGLIA: IMPLICATIONS FOR COGNITIVE FUNCTION 357
Nutraceuticals: opening the debate for a regulatory framework 354
A case-control study of visually evoked postural responses in childhood with primary headaches 346
Environmental enrichment influences mouse hippocampal neuroinflammatory response 338
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 336
Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review 335
Environmental quality modulates the endocannabinoid system along the gut-brain axis in a mouse model of LPS-induced neuroinflammation 316
Adherence to selective serotonin and serotonin-norepinephrine reuptake inhibitor prescriptions affects overall medication adherence in older persons: Evidence from the Italian nationwide osmed health-db database 315
Anti-CGRP monoclonal antibodies improve cognitive function in patients affected by chronic migraine complicated with medication overuse-headache 313
1-(2′,4′-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihy droindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice 311
Practical issues with amisulpride in the management of patients with schizophrenia 309
Sleep deprivation in the rat: an animal model of mania 306
Antipsychotic efficacy: Relationship to optimal D2-receptor occupancy 304
Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: A retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database 295
Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study 292
Ritanserin counteracts both rat vacuous chewing movements and nigro-striatal tyrosine hydroxylase-immunostaining alterations induced by haloperidol 290
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research 284
Clinical trials and late-stage drug development for Alzheimer's disease: An appraisal from 1984 to 2014 284
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 268
Dysbindin, D3 receptors, and their genetic interaction differently regulate neuroplasticity genes in the mouse brain 265
Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency 263
Association of neovascular age-related macular degeneration with month and season of birth in Italy 262
A network study to differentiate suicide attempt risk profiles in male and female patients with major depressive disorder 257
Stamina therapies: Let the record stand 255
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience 255
Comprehensive Analysis of Berberis aristata DC. Bark Extracts: In Vitro and In Silico Evaluation of Bioaccessibility and Safety 249
ACTH-induced mitochondrial DBI receptor (MDR) and diazepam binding inhibitor (DBI) expression in adrenals of hypophysectomized rats is not cause-effect related to its immediate steroidogenic action 249
Take This Cognitive Training Efficacy Bar Fight Outside (to a Regulatory Agency) 242
Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network 235
Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression 234
Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study 234
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 233
Time- and Region-specific Effect of Vortioxetine on Central LPS-induced Transcriptional Regulation of NLRP3 Inflammasome 232
A comparison of continuous subcutaneous paliperidone infusion and repeated subcutaneous injection of risperidone free-base in rats 232
The effects of novel and newly approved antipsychotics on serum prolactin levels: A comprehensive review 232
Circulating levels of anticonvulsant metabolites of progesterone in women with partial epilepsy in the intercritical phase 230
Cluster Headache Genomewide Association Study and Meta-Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor 228
The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein 228
Antinociceptive activity of Δ9-tetrahydrocannabinol non-ionic microemulsions 226
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin 224
First evidence of an anxiety-like behavior and its pharmacological modulation in a molluscan model organism, Lymnaea stagnalis 223
The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex 222
The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia 221
Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFA Anti-diabetics Monitoring Registry 221
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 220
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[ 3.1.1]heptanes as novel potent dopamine uptake inhibitors 220
Identification and characterization of the kynurenine pathway in the pond snail Lymnaea stagnalis 218
Different stressors uniquely affect the expression of endocannabinoid‐metabolizing enzymes in the central ring ganglia of Lymnaea stagnalis 217
Subthreshold depression in older subjects: An unmet therapeutic need 217
Occlusal splint therapy in patients with Ménière’s disease and temporomandibular joint disorder 217
Comparing safety information of biosimilars with their originators: a cross-sectional analysis of European risk management plans 215
Delta-9-tetrahydrocannabinol differently affects striatal c-Fos expression following haloperidol or clozapine administration 215
Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data 214
The placebo arm in clinical studies for treatment of Psychiatric Disorders: A Regulatory Dilemma 213
Is there an evolutionary mismatch between the normal physiology of the human dopaminergic system and current environmental conditions in industrialized countries? 213
Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid 212
Approaches to attenuated psychosis syndrome treatments: A perspective on the regulatory issues 210
Consensus on the use of substituted benzamides in psychiatric patients 210
Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic 209
Steps forward in regulatory pathways for acute and chronic heart failure 206
Use and reimbursement of off-label drugs in pediatric anesthesia: The Italian experience 205
Red Yeast Rice or Lovastatin? A Comparative Evaluation of Safety and Efficacy Through a Multifaceted Approach 203
Impact of reimbursement limits on patient access to direct-acting antivirals in Italy: Analysis of data from national registries 203
Evaluation of tamsulosin and alfuzosin activity in the rat vas deferens: Relevance to ejaculation delays 201
Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2′, 4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7] cyclohepta[1,2-c]pyrazole-3-carboxamide 201
Farmaci antidepressivi parte II: SNRI e farmaci multimodali 198
The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies 198
Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways 197
Kounis syndrome due to antibiotics: A global overview from pharmacovigilance databases 197
Alternative pricing strategies for cancer drugs 196
The future is now: Model-based clinical trial design for Alzheimer's disease 195
Digital Phenotyping and Dynamic Monitoring of Adolescents Treated for Cancer to Guide Intervention: Embracing a New Era 193
Weight loss induced by rimonabant is associated with an altered leptin expression and hypothalamic leptin signaling in diet-induced obese mice 190
Evaluation of amphetamine-induced hyperlocomotion and catalepsy following long-acting risperidone administration in rats 190
Revised criteria for the diagnosis and staging of Alzheimer’s disease 189
Evolutionary psychopharmacology, mental disorders, and ethical behavior 189
The endless frontier? The recent increase of R&D productivity in pharmaceuticals 188
Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic 188
Identification and validation of biomarkers for autism spectrum disorders 188
Role of dopamine D3 receptors, dysbindin, and their functional interaction on the expression of key genes for neuroplasticity in the mouse brain 187
Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB 2 cannabinoid ligand 1-(2′, 4′-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c] pyrazole-3-carboxamide 187
Behavioral and transcriptional effects of carnosine in the central ring ganglia of the pond snail Lymnaea stagnalis 187
Novel epigenetic target therapy for prostate cancer: A preclinical study 186
Blockade of neurotensin receptors affects differently hypo-locomotion and catalepsy induced by haloperidol in mice 186
Practical application of pharmacotherapy with long-acting risperidone for patients with schizophrenia 186
Contrasting effects of diazepam and repeated restraint stress on latent inhibition in mice 185
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials 185
Haloperidol, but not clozapine, produces dramatic catalepsy in Δ 9-THC-treated rats: Possible clinical implications 184
Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017) 183
OnabotulinumtoxinA: Still the Present for Chronic Migraine 183
Are "social drugs" (tobacco, coffee and chocolate) related to the bipolar spectrum? 183
High prevalence of poor quality drug prescribing in older individuals: A nationwide report from the Italian Medicines Agency (AIFA) 181
Small patient datasets reveal genetic drivers of non-small cell lung cancer subtypes using machine learning for hypothesis generation 180
Computational and functional analysis of biopharmaceutical drugs in zebrafish: Erythropoietin as a test model 180
Embracing the Healthcare Digital Revolution: pioneering an Ethical and Legal framework for Individual Participant Clinical Data Return 178
Monitoring registries at Italian medicines agency: Fostering access, guaranteeing sustainability 177
Anxious-excited depression. A mixed affective syndrome 177
Totale 25.167
Salva come PNG Salva come JPEG
Categoria #
all - tutte 203.248
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 203.248
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.266 0 0 0 0 70 180 162 105 369 345 730 305
2022/20233.065 321 160 162 245 320 446 44 479 449 54 303 82
2023/20242.038 128 146 121 197 383 136 79 264 77 59 91 357
2024/20257.857 139 55 118 581 1.352 1.231 746 267 856 349 857 1.306
2025/202614.980 855 756 1.301 1.519 1.436 1.214 1.701 839 1.167 1.614 1.304 1.274
2026/20277.681 982 1.660 1.650 2.609 780 0 0 0 0 0 0 0
Totale 44.141